New Delhi: India is expected to receive the first lot of anti-COVID shots in late January-early February. This lot will allow some frontline workers like doctors, nurses and municipal staff to get the dose of vaccine.
India is planning to give Serum Institute of India (SII) approval for emergency use of the Oxford-AstraZeneca vaccine candidate soon after it gets similar go-ahead in the United Kingdom, according to a report in The Times of India.
SII is expected to apply for necessary approval for emergency use in December. For the procurement of doses, the government will finalise a contract.
According to the report, the government has also negotiated a better price for bulk purchases. The likely MRP will be Rs 500-600 for the two-shot vaccine, an official source was quoted in the report.
“If everything goes as per plan and the company (SII) manages to secure emergency authorisation in December, we are expecting the first lot of vaccines by January-February and the first set of beneficiaries has been identified,” the official was quoted as saying by The Times of India.
Bhubaneswar: The Election Commission of India (ECI) on Thursday ordered the transfer of secretary of…
Mumbai: Everyone in India is a cricket expert and has an opinion on every debatable issue…
Bhubaneswar: The Central leaders of BJP have moved the Election Commission of India (ECI) against…
New Delhi: The process of granting citizenship under the Citizenship (Amendment) Act [CAA] will start…
Bhubaneswar: Social Media monitoring cell of Odisha Police has blocked 292 offensive posts related to…
Baripada: Police have arrested a woman for allegedly killing her husband in Odisha’s Mayurbhanj district.…
Kolkata: In a sensational charge, a female employee of Raj Bhavan has accused West Bengal…
Keonjhar: At least 10 labourers were reportedly injured in an explosion in a steel plant…